Bright Minds Biosciences Inc. (DRUG) is currently trading at $65.79 with a Wall Street consensus price target of $165.08, implying potential upside of 150.9% over the next 12 months. 3 analysts currently cover DRUG, with a consensus rating of Hold — 67% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $213.39, while the most cautious has a target of $139.8.
DRUG operates in the Healthcare sector with a market capitalisation of $646M. The stock is down 21.2% year-to-date and is currently trading near the lower end of its 52-week range of $23.18 – $123.75.
Other Healthcare stocks with comparable size and valuation.
Upgrade/downgrade history for DRUG, with each firm's 90-day track record across all stocks we track. See full firm rankings →
Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.
Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.
StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.
View Full Rankings →